RxDoctor Payments Data

Jenna Brown, APRN

Nurse Practitioner · Woodsfield, OHNPI 1851984595

Payments from drug & device makers

$252in general payments, 2019–2025

Across 16 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$58
  • AstraZeneca$39
  • Exact Sciences$34
  • Novo Nordisk$29
  • GSK$18
  • Esperion Therapeutics, Inc.$16
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$252100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$252 in reported general payments places this provider in the 70th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$896
Medicare patients
34
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol21$29,462
MounjaroTirzepatide12$25,587
Breztri AerosphereBudesonide/Glycopyr/Formoterol35$25,154
OzempicSemaglutide16$23,462
LinzessLinaclotide21$15,474
JanuviaSitagliptin Phosphate11$13,269
Combivent RespimatIpratropium/Albuterol Sulfate25$12,161
TradjentaLinagliptin13$8,456
SymbicortBudesonide/Formoterol Fumarate21$5,129
Albuterol Sulfate HfaAlbuterol Sulfate80$2,087
Atorvastatin Calcium111$1,369
Metoprolol Succinate103$1,351
Ezetimibe41$1,220
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,114
Levothyroxine Sodium123$1,080

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$39$59,74677 claims
Lilly USA, LLCMounjaro$14$25,58712 claims
Novo NordiskOzempic$29$23,46216 claims
AbbVieLinzess$16$15,47421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Woodsfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →